VC-Backed Stem Cell Cos. Merge
iZumi Bio Inc., a South San Francisco-based regenerative medicine company that uses induced pluripotent stem (iPS) cells, has merged with fellow stem cell company Pierian Inc. The merger is being financed by $11.5 million in new capital, including $10 million from existing Pierian backer MPM Capital. iZumi had previously raised $20 million from Highland Capital Partners and Kleiner Perkins Caufield & Byers. The combined company will be named iPierian Inc.
9 July 2009•7 mins read
